{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:07:24Z","timestamp":1790633244367,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Shanghai Educational Development Foundation, Shanghai Municipal Health Bureau and the National Natural Science Foundation of China","award":["30800612"],"award-info":[{"award-number":["30800612"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["C060501"],"award-info":[{"award-number":["C060501"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.bbrc.2014.10.096","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T02:07:12Z","timestamp":1414721232000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inherent lipid metabolic dysfunction in glycogen storage disease IIIa"],"prefix":"10.1016","volume":"455","author":[{"given":"Xin-Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Ming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.10.096_b0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/fampra\/cmp025","article-title":"Health outcomes following liver function testing in primary care: a retrospective cohort study","volume":"26","author":"McLernon","year":"2009","journal-title":"Fam. Pract."},{"key":"10.1016\/j.bbrc.2014.10.096_b0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/pmj.79.932.307","article-title":"Evaluation of abnormal liver function tests","volume":"79","author":"Limdi","year":"2003","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bbrc.2014.10.096_b0015","first-page":"1105","article-title":"Mildly elevated liver transaminase levels in the asymptomatic patient","volume":"71","author":"Giboney","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbrc.2014.10.096_b0020","first-page":"36","article-title":"The clinicopathological analysis of 88 patients with abnormal liver function test of unknown etiology","volume":"50","author":"Pang","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.bbrc.2014.10.096_b0025","first-page":"300","volume":"20","author":"Rong","year":"2012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.bbrc.2014.10.096_b0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2014.10.096_b0035","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3748\/wjg.v13.i18.2541","article-title":"Glycogen storage diseases: new perspectives","volume":"13","author":"Ozen","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2014.10.096_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.spen.2006.06.007","article-title":"Glycogen storage disease: clinical, biochemical, and molecular heterogeneity","volume":"13","author":"Shin","year":"2006","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.bbrc.2014.10.096_b0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2014.10.096_b0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10545-009-9000-2","article-title":"Clinical and biochemical monitoring of patients with fatty acid oxidation disorders","volume":"33","author":"Lund","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2014.10.096_b0055","doi-asserted-by":"crossref","unstructured":"D. Matern, P. Rinaldo, Medium-Chain Acyl-Coenzyme a Dehydrogenase Deficiency, 1993.","DOI":"10.1016\/S0022-3476(05)83539-5"},{"key":"10.1016\/j.bbrc.2014.10.096_b0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","article-title":"A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation","volume":"33","author":"Houten","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2014.10.096_b0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","article-title":"Glycogen storage disease in adults","volume":"120","author":"Talente","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2014.10.096_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1021831621210","article-title":"Glycogen storage diseases","volume":"4","author":"Wolfsdorf","year":"2003","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbrc.2014.10.096_b0075","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1089\/jir.2006.0163","article-title":"MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment","volume":"27","author":"Kong","year":"2007","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrc.2014.10.096_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3476(05)81652-X","article-title":"Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III","volume":"116","author":"Ding","year":"1990","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrc.2014.10.096_b0085","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/bioinformatics\/btp167","article-title":"KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor","volume":"25","author":"Zhang","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2014.10.096_b0090","doi-asserted-by":"crossref","first-page":"D277","DOI":"10.1093\/nar\/gkh063","article-title":"The KEGG resource for deciphering the genome","volume":"32","author":"Kanehisa","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2014.10.096_b0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici","year":"2007","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2014.10.096_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2105-7-30","article-title":"WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data","volume":"7","author":"Yi","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bbrc.2014.10.096_b0105","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/bioinformatics\/btn081","article-title":"Network-constrained regularization and variable selection for analysis of genomic data","volume":"24","author":"Li","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2014.10.096_b0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/bioinformatics\/btm129","article-title":"A Markov random field model for network-based analysis of genomic data","volume":"23","author":"Wei","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2014.10.096_b0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1101\/gr.205602","article-title":"Relating whole-genome expression data with protein-protein interactions","volume":"12","author":"Jansen","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.bbrc.2014.10.096_b0120","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.2032324100","article-title":"Protein complexes and functional modules in molecular networks","volume":"100","author":"Spirin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.096_b0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/mgme.1999.2953","article-title":"Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease","volume":"69","author":"Shaiu","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0130","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00652.2005","article-title":"Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways","volume":"291","author":"Greenberg","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1096-8628(20000731)93:3<211::AID-AJMG10>3.0.CO;2-Z","article-title":"Compound heterozygous patient with glycogen storage disease type III: identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin","volume":"93","author":"Okubo","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2014.10.096_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s100380200000","article-title":"Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III","volume":"47","author":"Horinishi","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2014.10.096_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2004.07.017","article-title":"DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese","volume":"83","author":"Lam","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0150","first-page":"85","article-title":"Huang SZ","volume":"43","author":"Zhuang","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.bbrc.2014.10.096_b0155","first-page":"416","volume":"47","author":"Wang","year":"2009","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.bbrc.2014.10.096_b0160","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-008-0919-5","article-title":"Hyperlipidemia in glycogen storage disease type III: effect of age and metabolic control","author":"Bernier","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2014.10.096_b0165","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/ajmg.a.33046","article-title":"Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia","volume":"149A","author":"Vivatrat","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbrc.2014.10.096_b0170","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPAR gamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2014.10.096_b0175","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tem.2009.04.005","article-title":"Functional implications of genetic variation in human PPAR gamma","volume":"20","author":"Jeninga","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0180","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.0306743102","article-title":"Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance","volume":"102","author":"Jones","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.096_b0185","doi-asserted-by":"crossref","first-page":"E1195","DOI":"10.1152\/ajpendo.00513.2004","article-title":"PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes","volume":"288","author":"Schadinger","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.10.096_b0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.10.096_b0200","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/hep.23813","article-title":"Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis","volume":"52","author":"Cole","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2014.10.096_b0205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.10.096_b0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"Savage","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2014.10.096_b0215","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver","volume":"88","author":"Westerbacka","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2014.10.096_b0220","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajhg.2009.10.014","article-title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip","volume":"85","author":"Talmud","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2014.10.096_b0225","doi-asserted-by":"crossref","first-page":"16480","DOI":"10.1073\/pnas.0706794104","article-title":"Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity","volume":"104","author":"Choi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.096_b0230","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1073\/pnas.0409451102","article-title":"Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice","volume":"102","author":"Oh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.10.096_b0235","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1073\/pnas.1733877100","article-title":"Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat\/high-carbohydrate diets","volume":"100","author":"Abu-Elheiga","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14019056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14019056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T21:20:33Z","timestamp":1565990433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14019056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0006291X14019056"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.096","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherent lipid metabolic dysfunction in glycogen storage disease IIIa","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}